Tropicamide Ophthalmic Solution, USP

Manufacturer
Akorn
Effective date
2022-07-01
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
8
Source
full-release
Hydrated at
2026-05-31 20:42:13

Label at a glance#

ProductTropicamide
Active ingredientTropicamide
Label structure14 sections

Indications and uses

For mydriasis and cycloplegia for diagnostic procedures.

Dosage and administration

For refraction, instill one or two drops of 1% solution in the eye(s), repeated in five minutes. If patient is not seen within 20 to 30 minutes, an additional drop may be instilled to prolong mydriatic effect. For examination of fundus, instill one or two drops of 0.5% solution 15 to 20 minutes prior to examination. Individuals with heavily pigmented irides may require higher strength or more doses. Mydriasis will...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Rx only

DESCRIPTION:

DESCRIPTION SECTION

Tropicamide Ophthalmic Solution, USP is an anticholinergic prepared as a sterile topical ophthalmic solution in two strengths. The active ingredient is represented by the structural formula:

Structural Formula
Structural Formula

C17H20N2O2         MW=284.36

Established name: Tropicamide

Chemical name: Benzeneacetamide, N-ethyl-α-(hydroxymethyl)-N-(4-pyridinylmethyl)-.

Each mL contains: Active: Tropicamide 0.5% (5 mg) or 1% (10 mg). Inactives: Edetate Disodium, Sodium Chloride, Hydrochloric Acid and/or Sodium Hydroxide (to adjust pH), Water for Injection. pH range 4.0 to 5.8. Preservative: Benzalkonium Chloride 0.01%.

CLINICAL PHARMACOLOGY:

CLINICAL PHARMACOLOGY SECTION

This anticholinergic preparation blocks the responses of the sphincter muscle of the iris and the ciliary muscle to cholinergic stimulation, dilating the pupil (mydriasis). The stronger preparation (1%) also paralyzes accommodation. This preparation acts in 15-30 minutes and the duration of activity is approximately 3-8 hours. Complete recovery from mydriasis in some individuals may require 24 hours. The weaker strength may be useful in producing mydriasis with only slight cycloplegia. Heavily pigmented irides may require more doses than lightly pigmented irides.

INDICATIONS AND USAGE:

INDICATIONS & USAGE SECTION

For mydriasis and cycloplegia for diagnostic procedures.

CONTRAINDICATIONS:

CONTRAINDICATIONS SECTION

Contraindicated in persons showing hypersensitivity to any component of this preparation.

WARNINGS:

WARNINGS SECTION

For topical use only — not for injection.

This preparation may cause CNS disturbances which may be dangerous in pediatric patients. The possibility of psychotic reactions and behavioral disturbances due to hypersensitivity to anticholinergic drugs should be considered.

Mydriatics may produce a transient elevation of intraocular pressure.

Remove contact lenses before using.

PRECAUTIONS:

PRECAUTIONS SECTION

GENERAL PRECAUTIONS SECTION

General: The lacrimal sac should be compressed by digital pressure for two to three minutes after instillation to avoid excessive systemic absorption.

INFORMATION FOR PATIENTS SECTION

Information for Patients: Do not touch dropper tip to any surface, as this may contaminate the solution. Patient should be advised not to drive or engage in potentially hazardous activities while pupils are dilated. Patient may experience sensitivity to light and should protect eyes in bright illumination during dilation. Parents should be warned not to get this preparation in their child's mouth and to wash their own hands and the child's hands following administration.

DRUG INTERACTIONS SECTION

Drug Interactions: Tropicamide may interfere with the antihypertensive action of carbachol, pilocarpine, or ophthalmic cholinesterase inhibitors.

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

Carcinogenesis, Mutagenesis, Impairment of Fertility: There have been no long-term studies done using tropicamide in animals to evaluate carcinogenic potential.

PREGNANCY SECTION

Pregnancy: Pregnancy Category C. Animal reproduction studies have not been conducted with tropicamide. It is also not known whether tropicamide can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Tropicamide should be given to a pregnant woman only if clearly needed.

NURSING MOTHERS SECTION

Nursing Mothers: It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when tropicamide is administered to a nursing woman.

PEDIATRIC USE SECTION

Pediatric Use: Tropicamide may rarely cause CNS disturbances which may be dangerous in pediatric patients. Psychotic reactions, behavioral disturbances, and vasomotor or cardiorespiratory collapse in children have been reported with the use of anticholinergic drugs (See WARNINGS). Keep this and all medications out of the reach of children.

ADVERSE REACTIONS:

ADVERSE REACTIONS SECTION

SPL UNCLASSIFIED SECTION

Ocular: Transient stinging, blurred vision, photophobia and superficial punctate keratitis have been reported with the use of tropicamide. Increased intraocular pressure has been reported following the use of mydri-atics.

SPL UNCLASSIFIED SECTION

Non-Ocular: Dryness of the mouth, tachycardia, headache, allergic reactions, nausea, vomiting, pallor, central nervous system disturbances and muscle rigidity have been reported with the use of tropicamide. Psychotic reactions, behavioral disturbances, and vasomotor or cardiorespiratory collapse in children have been reported with the use of anticholinergic drugs.

DOSAGE AND ADMINISTRATION:

DOSAGE & ADMINISTRATION SECTION

For refraction, instill one or two drops of 1% solution in the eye(s), repeated in five minutes. If patient is not seen within 20 to 30 minutes, an additional drop may be instilled to prolong mydriatic effect. For examination of fundus, instill one or two drops of 0.5% solution 15 to 20 minutes prior to examination. Individuals with heavily pigmented irides may require higher strength or more doses. Mydriasis will reverse spontaneously with time, typically in 4 to 8 hours. However, in some cases, complete recovery may take up to 24 hours.

HOW SUPPLIED:

HOW SUPPLIED SECTION

Tropicamide Ophthalmic Solution USP, 0.5% and 1% are supplied as sterile solutions in plastic dropper bottles.

  • 0.5%   NDC 17478-101-12 (15 mL)
  • 1%      NDC 17478-102-12 (15 mL)
  • 1%      NDC 17478-102-20 (2 mL)

STORAGE AND HANDLING SECTION

STORAGE: Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Do not refrigerate or store at high temperatures. Keep container tightly closed.

Akorn

Distributed by:
Akorn Operating Company LLC
Gurnee, IL 60031
TC00N Rev. 03/22

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal Display Panel Text for Container Label:

NDC 17478-101-12

Tropicamide

Ophthalmic

Solution, USP

0.5%

Sterile

15 mL

Rx only

For Topical Ophthalmic Use Only

Principal Display Panel Text for Container Label
Principal Display Panel Text for Container Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal Display Panel Text for Carton Label:

NDC 17478-101-12

Tropicamide

Ophthalmic

Solution, USP

0.5%

For Topical Ophthalmic

Use only.

Sterile

15 mL

Rx only [Akorn logo]

Principal Display Panel Text for Carton Label
Principal Display Panel Text for Carton Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal Display Panel Text for Container Label:

NDC 17478-102-12

Tropicamide

Ophthalmic

Solution, USP

1%

Sterile

15 mL

Rx only

For Topical Ophthalmic Use Only

Principal Display Panel Text for Container Label
Principal Display Panel Text for Container Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal Display Panel Text for Carton Label:

NDC 17478-102-12

Tropicamide

Ophthalmic

Solution, USP

1%

For Topical Ophthalmic

Use only.

Sterile

15 mL

Rx only [Akorn logo]

Principal Display Panel Text for Carton Label
Principal Display Panel Text for Carton Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
313521tropicamide 0.5 % Ophthalmic SolutionPSN8
314238tropicamide 1 % Ophthalmic SolutionPSN8
314238tropicamide 10 MG/ML Ophthalmic SolutionSCD8
313521tropicamide 5 MG/ML Ophthalmic SolutionSCD8
313521tropicamide 0.5 % Ophthalmic SolutionSY8
314238tropicamide 1 % Ophthalmic SolutionSY8

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
TROPICAMIDE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
0f7ae452-206d-4fc4-868d-56fc47074084Product name120231011
6e36a95f-fcff-e2d1-3f9b-17d0b7f9e28cProduct name220200603
41722ce4-2429-80d8-5977-d735f8eca6d6Product name120140508

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
17478-101-12Tropicamide1 in 1 CARTONSOLUTION/ DROPS18
17478-101-12Tropicamide15 mL in 1 BOTTLE, DROPPERSOLUTION/ DROPS158
17478-102-12Tropicamide1 in 1 CARTONSOLUTION/ DROPS18
17478-102-12Tropicamide15 mL in 1 BOTTLE, DROPPERSOLUTION/ DROPS158
17478-102-20Tropicamide1 in 1 CARTONSOLUTION/ DROPS18
17478-102-20Tropicamide2 mL in 1 BOTTLE, DROPPERSOLUTION/ DROPS28

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
17478-101TROPICAMIDE SOLUTION/ DROPS [AKORN]8Legacy NDC, 2 package rows20220706_329a3382-3718-4311-890f-97c6b7e0077c.zip
17478-102TROPICAMIDE SOLUTION/ DROPS [AKORN]8Legacy NDC, 4 package rows20220706_329a3382-3718-4311-890f-97c6b7e0077c.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
17478-102-12ML - Milliliter17478-102a40716e4-abb9-40f2-9f35-a8165d94b39512012-07-24
17478-101-12ML - Milliliter17478-101ea016d61-973f-447f-9aea-5c6074d56b6212012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
TropicamideACTIVE INGREDIENTN0A3Z5XTC62
TropicamideACTIVE MOIETYN0A3Z5XTC62
benzalkonium chlorideINACTIVE INGREDIENTF5UM2KM3W72
edetate disodiumINACTIVE INGREDIENT7FLD91C86K2
hydrochloric acidINACTIVE INGREDIENTQTT17582CB2
sodium chlorideINACTIVE INGREDIENT451W47IQ8X2
sodium hydroxideINACTIVE INGREDIENT55X04QC32I2
waterINACTIVE INGREDIENT059QF0KO0R2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
17478-10217478-102-12, 17478-102-20
17478-10117478-101-12

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 14 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 10 · 557 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
hydrochloric acidHYDROCHLORIC ACIDQTT17582CBINJECTION / INTRA-ARTICULARADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
hydrochloric acidHYDROCHLORIC ACIDQTT17582CBEMULSION / OPHTHALMICADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
sodium chlorideSODIUM CHLORIDE451W47IQ8XSOLUTION/ DROPS / AURICULAR (OTIC)18 mgExact identifier — unii candidate
134 equally ranked IID candidates
hydrochloric acidHYDROCHLORIC ACIDQTT17582CBINJECTION, POWDER, FOR SOLUTION / INTRA-ARTERIALADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
edetate disodiumEDETATE DISODIUM7FLD91C86KPOWDER, FOR SUSPENSION / ORAL285 mgExact identifier — unii candidate
77 equally ranked IID candidates
edetate disodiumEDETATE DISODIUM7FLD91C86KSOLUTION / NASAL100 mg/100mlExact identifier — unii candidate
77 equally ranked IID candidates
hydrochloric acidHYDROCHLORIC ACIDQTT17582CBINJECTION / SUBMUCOSALADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION / INTRALESIONAL0.9 %w/vExact identifier — unii candidate
134 equally ranked IID candidates
sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION / INTRA-ARTICULAR26 mgExact identifier — unii candidate
134 equally ranked IID candidates
hydrochloric acidHYDROCHLORIC ACIDQTT17582CBINJECTION / INTRADERMALADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SOLUTION / INTRADISCALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
hydrochloric acidHYDROCHLORIC ACIDQTT17582CBINJECTION, POWDER, FOR SOLUTION / INTRATUMORADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
benzalkonium chlorideBENZALKONIUM CHLORIDEF5UM2KM3W7SUSPENSION/ DROPS / OPHTHALMIC0.02 %w/vExact identifier — unii candidate
24 equally ranked IID candidates
sodium chlorideSODIUM CHLORIDE451W47IQ8XSUSPENSION / INTRATYMPANIC2 mgExact identifier — unii candidate
134 equally ranked IID candidates
benzalkonium chlorideBENZALKONIUM CHLORIDEF5UM2KM3W7CLOTH / TOPICALNAExact identifier — unii candidate
24 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32ISUSPENSION / ENDOTRACHEALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
sodium chlorideSODIUM CHLORIDE451W47IQ8XCREAM / TOPICAL0.4 %w/wExact identifier — unii candidate
134 equally ranked IID candidates
hydrochloric acidHYDROCHLORIC ACIDQTT17582CBSOLUTION / SUBCUTANEOUSADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
hydrochloric acidHYDROCHLORIC ACIDQTT17582CBINJECTION / INTRALESIONALADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
hydrochloric acidHYDROCHLORIC ACIDQTT17582CBINJECTION / SOFT TISSUEADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
hydrochloric acidHYDROCHLORIC ACIDQTT17582CBPOWDER, FOR SUSPENSION / ORAL125 mgExact identifier — unii candidate
148 equally ranked IID candidates
edetate disodiumEDETATE DISODIUM7FLD91C86KSUSPENSION / AURICULAR (OTIC)0.01 %w/vExact identifier — unii candidate
77 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR27 mgExact identifier — unii candidate
174 equally ranked IID candidates
edetate disodiumEDETATE DISODIUM7FLD91C86KINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS19 mgExact identifier — unii candidate
77 equally ranked IID candidates
hydrochloric acidHYDROCHLORIC ACIDQTT17582CBINJECTION, SOLUTION / SUBMUCOSALADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32IINJECTION / SOFT TISSUEADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
edetate disodiumEDETATE DISODIUM7FLD91C86KSOLUTION / RESPIRATORY (INHALATION)43 mgExact identifier — unii candidate
77 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
hydrochloric acidHYDROCHLORIC ACIDQTT17582CBSOLUTION / DENTALADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
sodium chlorideSODIUM CHLORIDE451W47IQ8XPOWDER, DENTIFRICE / DENTAL0.03 mg/mgExact identifier — unii candidate
134 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / INTRA-ARTICULARADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
hydrochloric acidHYDROCHLORIC ACIDQTT17582CBJELLY / TOPICALADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
edetate disodiumEDETATE DISODIUM7FLD91C86KGEL / VAGINAL5 mgExact identifier — unii candidate
77 equally ranked IID candidates
hydrochloric acidHYDROCHLORIC ACIDQTT17582CBINJECTION / INTRA-ARTERIAL840 mgExact identifier — unii candidate
148 equally ranked IID candidates
hydrochloric acidHYDROCHLORIC ACIDQTT17582CBINJECTION, EMULSION / SUBCUTANEOUSADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
edetate disodiumEDETATE DISODIUM7FLD91C86KDROPS / NASAL0.1 mg/1mlExact identifier — unii candidate
77 equally ranked IID candidates
edetate disodiumEDETATE DISODIUM7FLD91C86KINJECTION / INTRABURSAL0.01 %w/vExact identifier — unii candidate
77 equally ranked IID candidates
hydrochloric acidHYDROCHLORIC ACIDQTT17582CBEMULSION / TOPICALADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
sodium chlorideSODIUM CHLORIDE451W47IQ8XTABLET, COATED / ORAL54.7 mgExact identifier — unii candidate
134 equally ranked IID candidates
benzalkonium chlorideBENZALKONIUM CHLORIDEF5UM2KM3W7SHAMPOO / TOPICAL0.2 %w/wExact identifier — unii candidate
24 equally ranked IID candidates
edetate disodiumEDETATE DISODIUM7FLD91C86KDROPS / OPHTHALMIC0.05 %w/vExact identifier — unii candidate
77 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARYADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, SUSPENSION / INTRAVITREALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32ISUSPENSION, EXTENDED RELEASE / SUBCUTANEOUSNAExact identifier — unii candidate
174 equally ranked IID candidates
edetate disodiumEDETATE DISODIUM7FLD91C86KELIXIR / ORAL1.3 mg/5mlExact identifier — unii candidate
77 equally ranked IID candidates
sodium chlorideSODIUM CHLORIDE451W47IQ8XSOLUTION/ DROPS / OPHTHALMIC55 mgExact identifier — unii candidate
134 equally ranked IID candidates
sodium chlorideSODIUM CHLORIDE451W47IQ8XSOLUTION / INTRAVENOUS90 mgExact identifier — unii candidate
134 equally ranked IID candidates
sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION, SUSPENSION / INTRAMUSCULAR26 mgExact identifier — unii candidate
134 equally ranked IID candidates
hydrochloric acidHYDROCHLORIC ACIDQTT17582CBINJECTION / INTRACARDIACADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32IPOWDER, FOR SUSPENSION / ENDOTRACHEALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION, SUSPENSION / SUBCUTANEOUS0.8 %w/vExact identifier — unii candidate
134 equally ranked IID candidates
sodium chlorideSODIUM CHLORIDE451W47IQ8XSPRAY / NASAL30 mgExact identifier — unii candidate
134 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32ISOLUTION / RECTALNAExact identifier — unii candidate
174 equally ranked IID candidates
hydrochloric acidHYDROCHLORIC ACIDQTT17582CBSUSPENSION/ DROPS / AURICULAR (OTIC)ADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32ISOLUTION/ DROPS / OPHTHALMICADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
sodium chlorideSODIUM CHLORIDE451W47IQ8XDROPS / ORALNAExact identifier — unii candidate
134 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32IGEL / TOPICAL70 mgExact identifier — unii candidate
174 equally ranked IID candidates
hydrochloric acidHYDROCHLORIC ACIDQTT17582CBSOLUTION / URETERALADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
hydrochloric acidHYDROCHLORIC ACIDQTT17582CBINJECTION / RETROBULBARADJ PHExact identifier — unii candidate
148 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 2 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A040314-001TROPICACYLTROPICAMIDE0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A040314-001AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-2984e616aacf4f…
2026-08-18 06:07:402026-07A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-29caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-29011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-2931067a03dcf5…
2025-08-23 18:47 UTC2025-08A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-296a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-29fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-29b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-2903ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-292680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-295bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-29d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-29d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-2979d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-29301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-291e350fbaab3a…
2024-05-31 18:47 UTC2024-05A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-298072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-295c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-295d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-294b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-2974a2ff9319b5…
2022-03-09 01:35 UTC2022-03A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-29bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-29782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-2987673890dc5c…
2021-03-12 10:30 UTC2021-03A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-295aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-298869cabd3fbd…
2020-11-12 02:37 UTC2020-11A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-29c0c555d07b60…
2019-12-14 00:12 UTC2019-12A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-293f01610625f2…
2019-09-15 20:21 UTC2019-09A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-29b00525d2431f…
2019-07-19 19:46 UTC2019-07A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-29ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-296a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-291c564ffb4f44…
2023-12-20 04:57 UTC2023-12A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-29ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-29a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-299b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-29a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-293f0d92c62455…
2023-05-13 08:27 UTC2023-05A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-29053a50430f4f…
2023-01-26 05:58 UTC2023-01A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-293bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-293a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A040314-001TROPICACYL0.5%SOLUTION/DROPS / OPHTHALMICAT2000-09-29f41ea6bd6efb…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A040314-001AT184e616aacf4f…
2026-08-18 06:07:402026-07A040314-001AT1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A040314-001AT1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A040314-001AT131067a03dcf5…
2025-08-23 18:47 UTC2025-08A040314-001AT16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A040314-001AT1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A040314-001AT1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A040314-001AT103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A040314-001AT12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A040314-001AT15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A040314-001AT1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A040314-001AT1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A040314-001AT179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A040314-001AT1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A040314-001AT11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A040314-001AT18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A040314-001AT15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A040314-001AT15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A040314-001AT14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A040314-001AT174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A040314-001AT1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A040314-001AT1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A040314-001AT187673890dc5c…
2021-03-12 10:30 UTC2021-03A040314-001AT15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A040314-001AT18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A040314-001AT1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A040314-001AT13f01610625f2…
2019-09-15 20:21 UTC2019-09A040314-001AT1b00525d2431f…
2019-07-19 19:46 UTC2019-07A040314-001AT1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A040314-001AT16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A040314-001AT11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A040314-001AT1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A040314-001AT1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A040314-001AT19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A040314-001AT1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A040314-001AT13f0d92c62455…
2023-05-13 08:27 UTC2023-05A040314-001AT1053a50430f4f…
2023-01-26 05:58 UTC2023-01A040314-001AT13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A040314-001AT13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A040314-001AT1f41ea6bd6efb…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A040315-001TROPICACYLTROPICAMIDE1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A040315-001AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-2984e616aacf4f…
2026-08-18 06:07:402026-07A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-2931067a03dcf5…
2025-08-23 18:47 UTC2025-08A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-296a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-2903ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-292680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-295bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-2979d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-291e350fbaab3a…
2024-05-31 18:47 UTC2024-05A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-298072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-295c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-295d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-294b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-2974a2ff9319b5…
2022-03-09 01:35 UTC2022-03A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-2987673890dc5c…
2021-03-12 10:30 UTC2021-03A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-295aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-298869cabd3fbd…
2020-11-12 02:37 UTC2020-11A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29c0c555d07b60…
2019-12-14 00:12 UTC2019-12A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-293f01610625f2…
2019-09-15 20:21 UTC2019-09A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29b00525d2431f…
2019-07-19 19:46 UTC2019-07A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-296a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-291c564ffb4f44…
2023-12-20 04:57 UTC2023-12A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-299b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-293f0d92c62455…
2023-05-13 08:27 UTC2023-05A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29053a50430f4f…
2023-01-26 05:58 UTC2023-01A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-293bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-293a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29f41ea6bd6efb…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A040315-001AT184e616aacf4f…
2026-08-18 06:07:402026-07A040315-001AT1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A040315-001AT1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A040315-001AT131067a03dcf5…
2025-08-23 18:47 UTC2025-08A040315-001AT16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A040315-001AT1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A040315-001AT1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A040315-001AT103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A040315-001AT12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A040315-001AT15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A040315-001AT1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A040315-001AT1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A040315-001AT179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A040315-001AT1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A040315-001AT11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A040315-001AT18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A040315-001AT15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A040315-001AT15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A040315-001AT14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A040315-001AT174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A040315-001AT1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A040315-001AT1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A040315-001AT187673890dc5c…
2021-03-12 10:30 UTC2021-03A040315-001AT15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A040315-001AT18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A040315-001AT1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A040315-001AT13f01610625f2…
2019-09-15 20:21 UTC2019-09A040315-001AT1b00525d2431f…
2019-07-19 19:46 UTC2019-07A040315-001AT1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A040315-001AT16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A040315-001AT11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A040315-001AT1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A040315-001AT1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A040315-001AT19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A040315-001AT1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A040315-001AT13f0d92c62455…
2023-05-13 08:27 UTC2023-05A040315-001AT1053a50430f4f…
2023-01-26 05:58 UTC2023-01A040315-001AT13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A040315-001AT13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A040315-001AT1f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
b8946687-fd16-4405-8320-85fdb1f8d68b329a3382-3718-4311-890f-97c6b7e0077c2022-07-01Warnings, Adverse reactionsExact identifier
spl id: b8946687-fd16-4405-8320-85fdb1f8d68b
spl set id: 329a3382-3718-4311-890f-97c6b7e0077c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.